Lesaffre acquires Recombia Biosciences, a biotechnology company specializing in high-throughput genome editing and synthetic biology
Lesaffre , a major global player in fermentation for nearly 170 years, today announces the acquisition of Recombia Biosciences , a San Francisco Bay Area -based biotechnology company , in 2019 based on atechnology licensedfrom Stanford University . This acquisition…